EBRICTUS
Epidemiological Research Group in Stroke from Primary Care
This group comprises primary health care professionals from Terres de l'Ebre with an interest in the study of stroke from 2006, when the Stroke Code was implemented in this region. They collaborate with specialists in Cardiology and Neurology of the hospital Verge de la Cinta. Up to 2016, the research areas of this group were included in the PreCarTe Group: Cardiovascular Prevention Terres de l'Ebre, accredited by the Primary Care Research Institute IDIAP Jordi Gol (2012-2015) and more recently by the AGAUR, Generalitat de Catalunya SGR 2014-2016 (Agency for the Management of University and Research Grants, File 2014 SGR 1561). This group has developed a unique database through which three health regions (Terres de l'Ebre, Barcelona right and Vallès Occidental) have participated in the pilot of the implementation of the Atrial Fibrillation Health Care Route in Catalonia, under the auspices of the Catalan Health Service Department of Vascular Disease and the Terres de l’Ebre Emergencies Commission of the Catalan Health Service; and together with the Vall Hebron Institute of Research Foundation they are PIs in the Research in Atrial Fibrillation in Catalonia (AFRICAT); they also participate in the international, prospective, multicentre RIVER Registry (TRI08890), led by the Thrombosis Research Institute (London) to observe the management and short and long term results of non valvular atrial fibrillation treated with Rivaroxaban.
The group participates in the following projects
|
PI: Clua Espuny, Josep Lluis. Long survival after ischemic stroke and thombolysis in Catalonia. Differences by sex. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019 |
|
PI: Dalmau Llorca, Maria Rosa. Fibril·lació auricular no valvular en l'atenció primària de l'ICS: avaluació d'una eina informàtica dissenyada per millorar l'adequació del tractament anticoagulant i els resultats de salut. Funding: Departament de Salut. Duration: 2017 - 2019 |
The group participates in the following publications
|
Beyer-Westendorf J, Camm AJ, Fox KAA, Le Heuzey JY, Haas S, Turpie AGG, Virdone S, Kakkar AK; RIVER Registry Investigators. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER). Thromb J. 2019 ; 17:7. doi:10.1186/s12959-019-0195-7. Epub 2019 Apr 25. pmc:PMC6482585. PMID:31169831. |
|
Clua-Espuny JL, Abilleira S, Queralt-Tomas L, Gonzalez-Henares A, Gil-Guillen V, Muria-Subirats E, Ballesta-Ors J. Long-Term Survival After Stroke According to Reperfusion Therapy, Cardiovascular Therapy and Gender. Cardiol Res. 2019 Apr; 10(2):89-97. doi:10.14740/cr839. Epub 2019 Apr 11. pmc:PMC6469916. PMID:31019638. |
|
García-Berrocoso T, Palà E, Consegal M, Piccardi B, Negro A, Gill N, Penalba A, Huerga Encabo H, Fernández-Cadenas I, Meisel A, Meisel C, Jickling GC, Muñoz MÁ, Clúa-Espuny JL, Pedrote A, Pagola J, Juega J, Bustamante A, Montaner J. Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis. Transl Stroke Res. 2019 Sep; doi:10.1007/s12975-019-00730-x. Epub 2019 Sep 02. PMID:31475302. IF: 5,847. |
|
Palà E, Bustamante A, Clúa-Espuny JL, Acosta J, Gonzalez-Loyola F, Ballesta-Ors J, Gill N, Caballero A, Pagola J, Pedrote A, Muñoz MA, Montaner J. N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors. Front Neurol. 2019 ; 10:1226. doi:10.3389/fneur.2019.01226. Epub 2019 Nov 29. pmc:PMC6896906. PMID:31849809. IF: 2,635. |
|
Queralt-Tomas L, Clua-Espuny JL, Fernández-Saez J, Lleixà-Fortuño MM, Albiol-Zaragoza I, Gil-Guillen V, Carratala-Munuera C. Risk of Dependency: A Challenge for Health and Social Care Planning-Observational Stroke Cohort. Value Health. 2019 Oct; 22(10):1083-1091. doi:10.1016/j.jval.2019.05.009. Epub 2019 Aug 16. PMID:31563250. IF: 5,037. |
Indicators
|
Indicator |
2019 |
|---|---|
|
Researchers with PhD |
9 |
|
Total number of projects in which group members have participated |
4 |
|
Total number of projects in which the PI of the project has belonged to the group |
1 |
|
Total Funding |
125.032,44€ |
|
Scientific publications in indexed journals |
3 |
|
Total Impact factor |
13,52 |
|
Nº of articles in Q1 journals |
2 |
|
Q1 IF |
10,884 |
|
Nº of articles in Q2 journals |
0 |
|
Q2 IF |
